Polyhydroxylated steroids are regulators of body shape and size in higher organisms. In metazoans, intracellular receptors recognize these molecules. Plants, however, perceive steroids at membranes, using the membrane-integral receptor kinase BRASSINOSTEROID INSENSITIVE 1 (BRI1). Here we report the structure of the Arabidopsis thaliana BRI1 ligand-binding domain, determined by X-ray diffraction at 2.5 Å resolution. We find a superhelix of 25 twisted leucine-rich repeats (LRRs), an architecture that is strikingly different from the assembly of LRRs in animal Toll-like receptors. A 70-amino-acid island domain between LRRs 21 and 22 folds back into the interior of the superhelix to create a surface pocket for binding the plant hormone brassinolide. Known loss-and gain-of-function mutations map closely to the hormone-binding site. We propose that steroid binding to BRI1 generates a docking platform for a co-receptor that is required for receptor activation. Our findings provide insight into the activation mechanism of this highly expanded family of plant receptors that have essential roles in hormone, developmental and innate immunity signalling.
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Signal perception at the cell surface, and transduction of this signal to the cell's interior, are essential to all life forms. Plants have met this challenge in part by evolving membrane-integral receptor kinases. Many of these receptors are composed of an extracellular leucine-rich repeat (LRR) module and a cytoplasmic kinase domain, connected by a single membrane-spanning helix 1 . Receptors with this architecture (LRR-receptor kinase, LRR-RK), for example, regulate plant growth 2 , development 3, 4 and interactions with the environment 5, 6 . Their corresponding ligands range from small molecules 7 and peptides 8 to entire proteins 5 . The LRR-RK BRI1 (refs 2, 9) controls a steroid signalling pathway essential for plant growth 10 . Whereas animal steroid receptors are found predominantly in the nucleus 11 , BRI1 is localized at the plasma-membrane and in endosomes 12 . The following model for BRI1 activation has been proposed: in the absence of brassinosteroid, BRI1's kinase domain is kept in a basal state by its auto-inhibitory carboxy-terminal tail 13 , as well as by interaction with the inhibitor protein BKI1 (ref. 14) . Hormone binding to the extracellular domain of BRI1 (refs 7, 15) , in a region that includes a ,70 amino acid 'island' domain 16 , causes a change in the receptor (a conformational change in a preformed homodimer 13 or receptor dimerization), leading to autophosphorylation of the BRI1 kinase domain 17 , release of its C-terminal tail 13 , and trans-phosphorylation of the inhibitor BKI1 (refs 14, 18) . BKI1 then dissociates from the membrane, allowing BRI1 to interact with a family of smaller LRR-RKs 19 , including the BRI1 ASSOCIATED KINASE 1 (BAK1) 20, 21 . The kinase domains of BRI1 and BAK1 trans-phosphorylate each other on multiple sites 22 , and the fully activated receptor triggers downstream signalling events 23 , resulting in major changes in nuclear gene expression 10 . The architecture of BRI1 is reminiscent of animal Toll-like innate immunity receptors (TLRs), and notably several plant LRR-RKs are immunity receptors 5 . It was, thus, reasonable to assume that the BRI1 ectodomain would form a TLR-like horseshoe structure 24 that binds its ligand along a dimer interface, as observed in several TLRs 25, 26 . Here we report the structure of the ligand-binding domain of Arabidopsis BRI1 in its free form and bound to the steroid brassinolide, and show that BRI1 folds into a superhelical assembly, whose interior provides the hormone-binding site. Comparison of the free and hormone-bound structures, combined with genetic data, suggests a novel activation mechanism for BRI1 that is distinct from TLRs.
Overall structure of the BRI1 ectodomain BRI1 was expressed in baculovirus-infected insect cells and the secreted ectodomain was purified by tandem-affinity and sizeexclusion chromatography. The crystal structure was solved to 2.5 Å resolution by single isomorphous replacement (see Methods, Supplementary Table 1 and Fig. 1 ). BRI1 does not adopt the anticipated TLR-horseshoe structure but forms a right-handed superhelix composed of 25 LRRs (Fig. 1a) . The helix completes one full turn, with a rise of ,70 Å . The concave surface, which determines the curvature of the solenoid 27 , is formed by a-and 3 10 helices (green in Fig. 1a ) that produce inner and outer diameters of ,30 and ,60 Å , respectively. The overall curvature of BRI1 is similar to that of TLR3 (ref. 24 ; Fig. 1b) , but, whereas the TLR3 ectodomain is essentially flat, BRI1 is highly twisted (Fig. 1b) . Such twisted assemblies of LRRs have been observed previously with bacterial effector 28 and adhesion proteins 29 , and with the plant defence protein PGIP 30 ( Supplementary Fig. 2 ). The twist of PGIP's LRR domain is caused by a non-canonical, second b-sheet that is oriented perpendicular to the central b-sheet forming the inner surface of the solenoid 30 . Additional b-sheets are also present in our structure (blue in Fig. 1a, Supplementary Fig. 3 ), but in the case of the much larger BRI1 ectodomain result in a superhelical assembly (Fig. 1a) . The second b-strand in PGIP and in BRI1 is followed by an Ile-Pro spine that runs along the outer surface of the helix and provides packing interactions between consecutive LRRs (Fig. 2a and ref. 30 ). Both structural features are directly linked to the Lt/sGxIP consensus sequence of the plant-specific LRR subfamily 31 ( Fig. 2c, Supplementary Fig. 4 and Supplementary Table 2 ). Because this consensus sequence is found in other plant receptor kinases, these receptors may also harbour twisted LRR domains (Fig. 2c) , making BRI1 the primary template for the study of diverse signalling pathways in plants [3] [4] [5] [6] .
Amino-and C-terminal flanking regions that cap the hydrophobic core of the BRI1 solenoid are similar to caps previously described for PGIP 30 ( Supplementary Fig. 5 ). Notably, not only are these caps stabilized by disulphide bridges, but five additional disulphide bonds link consecutive LRR segments in the N-terminal half of the BRI1 ectodomain ( 
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The island domain
The island domain in BRI1 corresponds to a large insertion in the regular repeat-structure between LRRs 21 and 22 (residues 584-654; Fig. 1a ). The resulting ,70-residue segment forms a small domain that folds back into the interior of the superhelix, where it makes extensive polar and hydrophobic interactions with LRRs 13-25 (Fig. 1a, Supplementary Fig. 6 and Supplementary Table 2 ). The domain fold is characterized by an anti-parallel b-sheet, which is sandwiched between the LRR core and a 3 10 helix and stabilized by a disulphide bridge (Fig. 3a, Supplementary Fig. 4) . The loss-of-function alleles bri1-9 (Ser662Phe, weak) 32 and bri1-113 (Gly611Glu, strong) 2 map to this island domain-LRR interface ( Supplementary Fig. 6 ), and probably interfere with folding of the island domain 33 . Two long loops that connect the island domain to the LRR core appear partially disordered in the unliganded receptor ( Supplementary Fig. 7 ). The insertion of a folded domain into the LRR repeat has not been observed in other LRR receptor structures, and is probably an adaptation to the challenge of sensing a small steroid ligand (rather than larger ligands, such as proteins, nucleic acids, or lipids 25, 26 ). We next solved a 2.5 Å co-crystal structure with brassinolide, a potent Arabidopsis steroid that binds BRI1 with nanomolar affinity 7, 34 . One molecule of brassinolide per BRI1 monomer binds in close proximity to the island domain (Fig. 3a-c) , which was previously implicated in steroid binding 7, 16 . Our structure reveals that the LRR superhelix and the island domain both extensively contribute to formation of the hormone binding site. The A-D rings of the steroid bind to a hydrophobic surface, which is provided by LRRs 23-25 and that maps to the inner side of the BRI1 superhelix (Fig. 3b, d, Supplementary Fig. 8 ). The alkyl chain of the hormone fits into a small pocket formed by residues originating from LRRs 21 and 22 (Ile 563, Trp 564, Met 657, Phe 658) and from two loops connecting the island domain with the LRR core (Fig. 3d) . The hydrophobic nature and restricted size of this pocket now explain why steroid ligands with bulkier or charged alkyl side chains, such as the arthropod steroid ecdysone (Supplementary Fig. 8) , cannot be recognized by BRI1 (ref. 7) . A few polar interactions with brassinolide's second diol moiety (Fig. 3d) are established with Tyr 597 and main-chain atoms from His 645 and Ser 647 in the island domain, and are mediated by water molecules (Fig. 3d) . Mutation of the neighbouring Gly 644 to Asp may interfere with this hydrogen-bonding network, and explain why this mutation greatly reduces the binding activity of the receptor 7 and causes the loss-of-function phenotype bri1-6 (ref . 32; Fig. 3d) . No polar contacts are observed with the seven-membered B-ring lactone (Fig. 3d) , consistent with B-ring modifications as found in, for example, castasterone ( Supplementary  Fig. 8) being tolerated by BRI1 (refs 7, 35) .
The steroid-complex reveals a hormone-binding site that involves a much larger portion of the LRR domain than previously anticipated 16 .
Major interactions between the steroid and the BRI1 ectodomain originate from the very C-terminal LRRs 23-25, which bring the hormone in close proximity to the membrane (Fig. 3a,d ). Importantly, while there is a significant hormone-receptor interface (550 Å 2 ) for such a small molecule ligand, large parts of the steroid are exposed to the solvent, including the 2a,3a-diol moiety in brassinolide that is important for biological activity 35 . Thus, protein-protein interactions may be involved in the recognition of the steroid ligand, with the hormone itself providing a docking platform. Importantly, steroid binding induces a conformational rearrangement and fixing of the island domain, which becomes fully ordered and competent to participate in protein-protein interactions that could be critical for receptor activation ( Supplementary Fig. 7 ). 
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A protein interaction platform
Four known BRI1 mis-sense alleles map to the inner surface of the last five LRRs (Fig. 4a) . This surface is not masked by carbohydrate ( Supplementary Fig. 9 ), and contains both the hormone-binding site and the island domain (Figs 3a, d and 4a ). Three mutations cluster in a loop connecting the island domain with LRR 22 (Fig. 4a) . This loop is partially disordered in the unliganded structure but is well-defined in the brassinolide complex ( Supplementary Fig. 7 ). We speculate that this loop, when ordered, is engaged in protein-protein interactions that are critical for receptor activation, and that mis-sense alleles in BRI1 modulate these interactions. The gain-of-function allele sud1 (ref. 36; Gly643Glu) may establish contact with Ser 623 in the island domain, and lead to an ordered loop even in the absence of steroid ligand ( Supplementary Fig. 10) Fig. 10 ), and thus may distort the position of the loop. Interestingly, bri1-102, a strong loss-of-function mutation (Thr750Ile) 38 that does not affect steroid binding 7 , maps to a distinct surface area in LRR 25 (Fig. 4a) . Thus protein-protein interactions critical for receptor activation may not be restricted to the island domain, but also involve residues from the LRR core.
Receptor activation
BRI1 has been shown to exist at least partially as a homo-oligomer in planta 13, 39, 40 . Thus steroid binding to the island domain and the concomitant rearrangements of the island domain loop could induce a conformational change in a preformed BRI1 homodimer 13 , or allow for ligand-dependent dimerization of the BRI1 ectodomain. However, models of BRI1 dimers that bring the C termini of their ectodomains into close proximity (we note that the cytoplasmic kinase domains of BRI1 can interact 13, 18 ) and that make use of the interaction surface outlined above, encounter steric clashes with the N-terminal LRRs ( Supplementary Fig. 11 ). Furthermore, in contrast to TLR ectodomains, which in crystals tend to form homodimers even in the absence of ligand 24, 25 , dimers cannot be seen in BRI1 crystals grown under the same acidic pH conditions that are typically associated with the plant cell wall. The largest interface area between two neighbouring BRI1 molecules amounts to only ,1.5% of the total accessible surface area, consistent with the high solvent content of our crystals (see Supplementary Methods). The main crystal contact involves a head-tohead arrangement of two BRI1 monomers, a configuration that would place the cytoplasmic kinase domains far apart (Supplementary Fig.  12 ). In size-exclusion chromatography experiments, the recombinant BRI1 ectodomain elutes as a monomer in the absence of steroid ligand, and shows no tendency to dimerize or oligomerize in the presence of a ,4 times molar excess of brassinolide (Fig. 4b) .
Our analyses suggest that the superhelical BRI1 LRR domain alone has no tendency to oligomerize, indicating that BRI1 receptor activation may not be mediated by ligand-induced homodimerization of the ectodomain (as described for TLRs 25, 26 ) or by conformational changes in preformed homodimers 13 . We do not dismiss the facts that the cytoplasmic kinase domain of BRI1 can dimerize 18 , or that BRI1 homooligomers are present in vivo 13, 39, 40 . However, our structures reinforce the notion that homo-oligomerization of BRI1 may be constitutive and independent of ligand stimulus 39 . The presence of an interaction platform that undergoes conformational changes when steroid binds and that harbours several loss-and gain-of-function alleles suggests that interaction with another protein factor may control BRI1 activation.
Discussion
The structure of the BRI1 ectodomain offers several new insights, and its twisted shape is likely to characterize the architecture of many plant LRR-RKs 1 . The presence of a folded-domain insert appears to be an adaptation to the recognition of a small molecule ligand, a challenge that smaller LRR proteins have met by generating loop insertions into their capping motifs 41 . BRI1's fascinating mode of ligand recognition reveals how steroids can be sensed at membranes and rationalizes a large set of genetic and biochemical findings 2, 7, 32, 38 . Different BRI1 receptor activation mechanisms have been proposed, including ligand-dependent dimerization as seen for TLRs 25, 26 and ligand-induced conformational changes in preformed homodimers 13 . Our analyses suggest that the superhelical shape of the BRI1 ectodomain is incompatible with homodimerization, and that the isolated ectodomain behaves as a monomer even in the presence of steroid. These findings leave us with the alternative hypothesis that another protein factor could bind to the interaction platform in BRI1 that would minimally encompass the steroid ligand, LRRs 21-25 and parts of the island domain (Fig. 4a) . Although it is possible that an unknown protein fulfils this role and provides a dimerization interface for two BRI1 molecules (as seen, for example, for TLR4; ref. 26) , genetic and biochemical screens have not uncovered this protein. It is thus possible that the small receptor kinase BAK1 acts as a direct brassinosteroid coreceptor, as suggested previously 10, 20 . It has been demonstrated that BAK1 is a genetic component of the brassinosteroid pathway 20, 21 , that BRI1 and BAK1 interact in a steroid-dependent manner 22 and that both receptors trans-phosphorylate each other on ligand stimulus 22 .
Notably, a homology model of the BAK1 ectodomain ( Supplementary  Fig. 13 ) is compatible in size and shape with the interaction platform in BRI1, and the BAK1 elg allele, which maps to the BAK1 ectodomain ( Supplementary Fig. 14) , renders plants hypersensitive to brassinosteroid treatment 42 . We speculate that the sud1, bri1-6, bri1-102 and elg mutations modulate the interaction between the BRI1 and BAK1 ectodomains in a brassinosteroid-dependent manner (Supplementary Fig.  14) . The demonstration that BAK1 is essential for brassinosteroid sensing may have been obscured owing to genetic redundancy 20 , with at least two BAK1-like proteins interacting with BRI1 in vivo 43, 44 . We recently overcame this limitation by showing that the BRI1 inhibitor protein BKI1 blocks the interaction between the BAK1 and BRI1 kinase domains 18 . Importantly, transgenic lines that constitutively deliver BKI1 to the site of BRI1 signalling resemble strong BRI1 lossof-function mutants, suggesting an important role for receptor-coreceptor association in brassinosteroid signal initiation 18 . Future studies will undoubtedly test this heteromerization model and dissect the relative contributions of the BRI1 and BAK1 ectodomains, their transmembrane segments and their cytoplasmic kinase domains to receptor activation. It will become important then to and total volume (V t ) are shown, together with elution volumes for molecular mass standards (A, aldolase, molecular mass 158,000 Da; B, conalbumin, molecular mass 75,000 Da). The calculated molecular mass for the monomer peak is ,125 kDa. The molecular mass of purified BRI1 is ,110 kDa.
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understand how BAK1 could serve as co-receptor for other LRR-RK signalling pathways 5, 19 .
METHODS SUMMARY
The BRI1 ectodomain (residues 29-788) was produced by secreted expression in baculovirus-infected insect cells, harvested 4 d after infection by ultrafiltration and purified by tandem-affinity chromatography, then by gel filtration. BRI1 was concentrated to 15 mg ml 21 and crystallized by vapour diffusion using a reservoir solution containing 14% PEG 4,000, 0.2 M (NH 4 ) 2 SO 4 , 0.1 M citric acid (pH 4.0). The brassinolide complex was obtained by co-crystallization. Diffraction data to 2.5 Å resolution were collected on a rotating anode X-ray generator and at beamline 8.2.1 of the Advanced Light Source (ALS), Berkeley. The structure was solved using the single isomorphous replacement method. Data and refinement statistics are summarized in Supplementary Table 1 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
